These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 17874175)

  • 1. Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.
    Sahdev S; Khattar SK; Saini KS
    Mol Cell Biochem; 2008 Jan; 307(1-2):249-64. PubMed ID: 17874175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant protein folding and misfolding in Escherichia coli.
    Baneyx F; Mujacic M
    Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
    Chou CP
    Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
    Sharma A; Chaudhuri TK
    Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli.
    Rabhi-Essafi I; Sadok A; Khalaf N; Fathallah DM
    Protein Eng Des Sel; 2007 May; 20(5):201-9. PubMed ID: 17430974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New advances in production and functional folding of G-protein-coupled receptors.
    Banères JL; Popot JL; Mouillac B
    Trends Biotechnol; 2011 Jul; 29(7):314-22. PubMed ID: 21497924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for production of active eukaryotic proteins in bacterial expression system.
    Khow O; Suntrarachun S
    Asian Pac J Trop Biomed; 2012 Feb; 2(2):159-62. PubMed ID: 23569889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
    Sørensen HP; Mortensen KK
    J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and effective strategy for solving the problem of inclusion bodies in recombinant protein technology: His-tag deletions enhance soluble expression.
    Zhu S; Gong C; Ren L; Li X; Song D; Zheng G
    Appl Microbiol Biotechnol; 2013 Jan; 97(2):837-45. PubMed ID: 23250226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytically-active inclusion bodies for biotechnology-general concepts, optimization, and application.
    Jäger VD; Lamm R; Küsters K; Ölçücü G; Oldiges M; Jaeger KE; Büchs J; Krauss U
    Appl Microbiol Biotechnol; 2020 Sep; 104(17):7313-7329. PubMed ID: 32651598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baculoviral polyhedrin as a novel fusion partner for formation of inclusion body in Escherichia coli.
    Seo JH; Li L; Yeo JS; Cha HJ
    Biotechnol Bioeng; 2003 Nov; 84(4):467-73. PubMed ID: 14574705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology.
    Gatti-Lafranconi P; Natalello A; Ami D; Doglia SM; Lotti M
    FEBS J; 2011 Jul; 278(14):2408-18. PubMed ID: 21569207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements.
    Kaur J; Kumar A; Kaur J
    Int J Biol Macromol; 2018 Jan; 106():803-822. PubMed ID: 28830778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
    Yan X; Hu S; Guan YX; Yao SJ
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant protein secretion in Escherichia coli.
    Mergulhão FJ; Summers DK; Monteiro GA
    Biotechnol Adv; 2005 May; 23(3):177-202. PubMed ID: 15763404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparative expression of secreted proteins in bacteria: status report and future prospects.
    Georgiou G; Segatori L
    Curr Opin Biotechnol; 2005 Oct; 16(5):538-45. PubMed ID: 16095898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
    Franzmann TM
    Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of recombinant mink growth hormone in E. coli.
    Sereikaite J; Statkute A; Morkunas M; Radzevicius K; Borromeo V; Secchi C; Bumelis VA
    Appl Microbiol Biotechnol; 2007 Feb; 74(2):316-23. PubMed ID: 17103160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in heterologous protein production in Escherichia coli.
    Hockney RC
    Trends Biotechnol; 1994 Nov; 12(11):456-63. PubMed ID: 7765545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.